3SBio Inc. Announces Unaudited Second Quarter 20... (otal operating expenses (75457) ...)

3SBio Inc. Announces Unaudited Second Quarter 2009 Results

Date:8/11/2009

otal operating expenses (75,457) (11,001) Operating income 29,378 4,283 Other income /(expenses), net Interest income 12,576 1,834 -- Grant income 187 27 -- Others 3,819 557 -- Total other income, net 16,582 2,418 Income before income tax expense and minority interests 45,960 6,701 Income tax expense (6,920) (1,009) -- Income before minority interests 39,040 5,692 Minority interests, net of tax 95 14 -- Net income 39,135 5,706 Net income per share: Basic and diluted 0.26 0.04 Basic weighted average number of shares outstanding 152,099,155 152,099,155 Effect of dilutive potential shares 4,318 4,318 Diluted weighted average number of shares outstanding 152,103,473 152,103,473 Net income per ADS: Basic and diluted 1.80 0.26 Basic weighted average number of ADSs outstanding 21,728,451 21,728,451 Effect of dilutive potential ADSs 617 617 Diluted weighted average number of ADSs outstanding 21,729,068 21,729,068 Non-GAAP Non-GAAP RMB US$ Net Revenues: EPIAO 72,594 10,583 TPIAO 31,476 4,589 Intefen 2,392 349 Inleusin

SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Related medicine news :

1. 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
2. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
3. 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
4. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
5. 3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference
6. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
7. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
8. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Leading Medical Developer Announces Plans for Texoma Medical Plaza
10. iMedX Announces Investment of $13M From RFE Investment Partners
11. Health Market Science Announces Commercial Release of CompleteSpend V2.5

Post Your Comments:

(Date:12/1/2009)...Medical Center in Oak Lawn, Ill. has become the st...e first for Chicago’s south and southwest su...squo;s plans today (December 1) by the Illinois He... Springfield, Ill. (Vocus) -- ...has become the state’s newest kidney transpl...

(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, The Future of Central Nervous System Disea...titive Benchmarking, Product Pipeline and Deals An...4/The-Future-of-Central-Nervous-System-Diseases-Th...Benchmarking-Product-Pipeline-and-Deals-Analysis.h...

(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Monoclonal Antibodies - Mar...roduct Pipeline and Deals Analysis ,, http://...onal-Antibodies---Market-Forecasts-to-2015-Competi...sis.html ,, Summary ,, The author has re...

(Date:12/1/2009)...USNewswire/ -- The Kerlan Jobe Orthopaedic Clinic,...ed to pay the United States $3 million to settle a... HealthSouth Corporation, the Justice Department a... allegations that HealthSouth paid kickbacks to Ke...tions to the Kerlan Jobe Foundation, loan forgiven...

(Date:12/1/2009)...wire-USNewswire/ -- A scientist who broadened the ...s we can control and relieve it -- has won the 201...ychology. ,, Ronald Melzack, psychology profess...selected for the award from among 24 nominations. ...but instead in their brain through a pathway that ...

[1] State Approves Plans For Kidney Transplants At Advocate Christ Medical Center [0] Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [1] Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Scientist Who Helps Explain Pain Wins Grawemeyer Award

...and heart muscle cells from rabbits, by researcher... have provided// a potential molecular explanation...ricular tachyarrhythmias (VTs) that can cause the ...e cells of the heart through Na+ channels are pred...

...own to underlie a form of Parkinson's disease (PD)...nd branching of neurons//, researchers have found....in made by mutant forms of the gene called LRRK2 a...nnections among such neurons is an early feature o...

...es are the true influencers of the "ultra thin" tr...sic.com, Twiggy says thin actresses go on extreme ...ing disorders among fans. She wants to see more cu...ls are naturally long and gangly, while a lot of t...

...itals, nursing homes, Diagnostic centres will soon...mum standards specified by law –// according to a ...een finalised by the Health Ministry and is being ...e same parameters will apply to a hospital, be it ...

...roduction in mice with type 2 diabetes, demonstrat...iabetes, say Tulane University gene// therapy rese... in the Early Edition of the Proceedings of the Na...se of their ability to repair many tissues in the ...

...logy, Jadavpur University, Kolkata and Department ... Andhra Pradesh done a// study on Plumeria Acumina...to evaluate the anti-inflammatory activity of meth... Plumeria Acuminata belongs to the family of Apoc...

Other Medicine News:Health News:Parkinson's Mutation Stunts Neurons 2 Health News:Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves 2

Altered Sodium Channel Function Linked to Heart Failure Parkinson's Mutation Stunts Neurons Twiggy Slams Ultra Thin Actresses Registration Compulsory For Nursing Homes, Clinics – Says A New Proposed Law By Health Ministr Adult Stem Cells Show Potential for Diabetes Solution Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves

(Date:12/1/2009)... , MONTREAL and DUSSELDORF, Germany, D...ading manufacturer of specialized graphics solutio...bH is now shipping the Matrox Xenia(TM) Series di... and Mammography solutions using Fujifilm Synapse...in computer based radiography, offering the world,...

(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, HPLC ... ,, http://www.reportlinker.com/p0164366/HPLC-... ,, Over the years, Liquid Chromatography has e... pharmaceuticals, food and beverage, research and ...

(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Lati...Policy environment, market analysis, forecasts and...inker.com/p0165648/Latin-American-Pharmaceutical-M...alysis-forecasts-and-growth-opportunities.html ...

Breaking Medicine Technology:FUJIFILM Europe Teams Synapse with Matrox Xenia 2 FUJIFILM Europe Teams Synapse with Matrox Xenia 3 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6 Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7 Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8 Drinking Weight Depression Linked in Young Women 3A Study 57563 1 Drinking Weight Depression Linked in Young Women 3A Study 57563 2 Childhood Stroke More Common Than Thought 57559 1 Childhood Stroke More Common Than Thought 57559 2 Childhood Stroke More Common Than Thought 57559 3 Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 1 Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 2 Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 3

[0] FUJIFILM Europe Teams Synapse with Matrox Xenia [0] Reportlinker Adds HPLC Systems & Accessories - A World Market Review [0] Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities

... 2 Pharmaleads has obtained from the,French Medic...a single,ascending dose Phase I study with PL37, i... pain., Neuropathic pain is a major chronic pain ...ld,s population of up to 6%, according to the most..., herpes, diabetes,antiviral or antitumor chemothe...

...Dual Modes of Action and Synergy with Chemotherapy...TC Bulletin Board: ACCP) presented data this week ...by blocking lactadherin, Angiolix has both,an anti...erative effect on,tumors themselves. In preclinica...d a significant anti-cancer effect in vivo; this e...

Other Medicine Technology:Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2 Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2 Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3

Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody

Classic Series Gel

...-transparent gel bed using small sliding baffles t...unit using a UV-transparent gel tray sealed with t... are offered for any color-coding your lab require...d. Gel tray is not included with the Mini-Gel unit...

...a V-2 includes all components necessary for castin...equiring a minimal amount of benchspace. The direc...f leads and cords on the bench and saves space. De...y can detect when the gel box cover is absent or r...

... very fast and clear separation of DNA restriction... user to cast, run, and perform Southern or Northe...: 1 x electrophoresis tank and cover, 1 x Gel Make...x MT-T02 (50 x 60 mm tray), 1 x MT-C01 (Analytical...

Medicine Products:

Classic Series Gel Horizontal Submarine Electrophoresis units Ultra Gel XL Electrophoresis System Wide Mini Horizontal Gel System

3SBio Inc. Announces Unaudited Second Quarter 20...(otal operating expenses (75457) ...),Health